Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,285.00
Bid: 1,278.00
Ask: 1,279.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.078%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,285.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Indivior says US filings "administrative", no new Suboxone settlements

Wed, 28th Apr 2021 10:47

(Alliance News) - Indivior PLC on Wednesday said recent US state filings made in relation to settlements are just "administrative in nature" and reflect previously struck agreements.

The pharmaceutical firm noted several US states have filed announcements on agreements with Indivior in relation to its Suboxone film.

"The various state settlement agreements being announced this week are administrative in nature, and simply formalize the individual state settlements which were previously agreed to in principle as part of the July 2020 criminal and civil resolution between Indivior and the states," the company said.

"As such, there is no new financial or legal obligation that has arisen. The company was pleased to put those issues behind it in 2020 and remains focused on realizing its patient-focused Vision and fulfilling its compliance commitments."

In mid-July, Indivior agreed to part with USD600 million to resolve fraud charges with the US Justice Department in relation to Suboxone.

Indivior shares were 2.5% higher at 146.20 pence each in London on Wednesday morning.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
29 Jun 2020 10:29

Indivior Names Promotes Finance Head Crossley To CEO, Thaxter Departs

Indivior Names Promotes Finance Head Crossley To CEO, Thaxter Departs

Read more
29 Jun 2020 08:57

LONDON MARKET OPEN: Energean Drops Norway Assets From Edison Deal

LONDON MARKET OPEN: Energean Drops Norway Assets From Edison Deal

Read more
29 Jun 2020 07:44

Indivior appoints Mark Crossley as CEO

(Sharecast News) - Indivior has promoted Mark Crossley to the role of chief executive officer, succeeding Shaun Thaxter.

Read more
24 Jun 2020 14:46

Indivior Reports Data From Transition Phase Of Opioid Recovery Study

Indivior Reports Data From Transition Phase Of Opioid Recovery Study

Read more
17 Jun 2020 13:18

Wednesday broker round-up

(Sharecast News) - Indivior: Jefferies reiterates hold with a target price of 70p.

Read more
17 Jun 2020 09:32

UK BROKER RATINGS SUMMARY: Goldman Sachs Upgrades WPP To Buy

UK BROKER RATINGS SUMMARY: Goldman Sachs Upgrades WPP To Buy

Read more
15 Jun 2020 08:52

Indivior Chair Howard Pien Takes Medical Leave Of Absence

Indivior Chair Howard Pien Takes Medical Leave Of Absence

Read more
3 Jun 2020 10:36

Indivior Considers Appeal Options For Suboxone Patent Ruling

Indivior Considers Appeal Options For Suboxone Patent Ruling

Read more
14 May 2020 12:33

Indivior Posts Quarterly Loss As Suboxone Competitor Hits Market Share

Indivior Posts Quarterly Loss As Suboxone Competitor Hits Market Share

Read more
7 May 2020 16:28

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
30 Apr 2020 16:06

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
27 Apr 2020 10:22

Indivior Non-Exec Director Tatjana May To Step Down For New Career

Indivior Non-Exec Director Tatjana May To Step Down For New Career

Read more
23 Apr 2020 16:13

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
16 Apr 2020 12:18

Positive Long-Term Safety Data From Indivior Sublocade Injection Study

Positive Long-Term Safety Data From Indivior Sublocade Injection Study

Read more
8 Apr 2020 12:22

Indivior Withdraws Guidance As Covid-19 Hurts Drug Enrolment

Indivior Withdraws Guidance As Covid-19 Hurts Drug Enrolment

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.